Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02776566 · ClinicalTrials.gov registry record · NA

Patient-Centered Anticoagulation Self-Monitoring in Minority Patients

A NA study of Cardiovascular Disease and Vascular Disease, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
86
Enrollment target
1
Study location

NCT02776566 is a NA study of Cardiovascular Disease and Vascular Disease that has completed, run by University of Illinois at Chicago. The registered enrollment target is 86 participants, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02776566, a NA study of Cardiovascular Disease and Vascular Disease, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to demonstrate the feasibility and effectiveness of anticoagulation self-monitoring coupled with an educational intervention in a minority underserved population.

Interventions

  • OTHER Patient Self-Monitoring vs Anticoagulation Clinic

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2016-01
Est. Completion 2019-02
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT02776566

The ClinicalTrials.gov registry entry for NCT02776566 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (97% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Patient Self-Monitoring vs Anticoagulation Clinic is the first listed.

NCT02776566 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT02776566 about?

NCT02776566 is a clinical study titled "Patient-Centered Anticoagulation Self-Monitoring in Minority Patients". The purpose of this study is to demonstrate the feasibility and effectiveness of anticoagulation self-monitoring coupled with an educational intervention in a minority underserved population.

What is the current status of trial NCT02776566?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2016-01. Estimated completion is 2019-02.

What conditions does trial NCT02776566 study?

This clinical trial studies the following conditions: Cardiovascular Disease, Vascular Disease, Thromboembolism, Blood Coagulation Disorders.

What interventions are being tested in trial NCT02776566?

The interventions under investigation include: Patient Self-Monitoring vs Anticoagulation Clinic (OTHER).

Who is sponsoring clinical trial NCT02776566?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02776566 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.